Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248Steven P Treon, Zachary R Hunter, Jeffrey Matous, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström MacroglobulinemiaSteven P Treon, Kirsten Meid, Joshua Gustine, et al.
American Journal of Hematology|September 7, 2006
Hepatitis C viral infection is not associated with Waldenström's macroglobulinemiaXavier Leleu, Kelly O'Connor, Allen W Ho, et al.
Blood Cancer Journal|December 23, 2024
Integration of clinical outcomes and molecular features in extramedullary disease in multiple myelomaRie Nakamoto-Matsubara, Valentina Nardi, Nora Horick, et al.
Blood Advances|March 8, 2021
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasiasAndrew R Branagan, Eamon Duffy, Geliang Gan, et al.
British Journal of Haematology|March 13, 2021
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemiaJoshua N Gustine, Lian Xu, Guang Yang, et al.
Blood|March 31, 2025
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatmentViktoria Blumenberg, Benjamin R Puliafito, Charlotte E Graham, et al.
Blood Advances|December 29, 2021
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapyJorge J Castillo, Shayna R Sarosiek, Joshua N Gustine, et al.
Blood|November 16, 2023
Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemiaJorge J Castillo, Andrew R Branagan, David Sermer, et al.
Blood|January 18, 2006
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemiaSteven P Treon, Morie A Gertz, Meletios Dimopoulos, et al.
Pageof 6